Thomas Lancaster
Overview
Explore the profile of Thomas Lancaster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goya-Maldonado R, Erwin-Grabner T, Zeng L, Ching C, Aleman A, Amod A, et al.
ArXiv
. 2025 Feb;
PMID: 39975425
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in...
2.
Belov V, Erwin-Grabner T, Aghajani M, Aleman A, Amod A, Basgoze Z, et al.
Sci Rep
. 2024 Jan;
14(1):1084.
PMID: 38212349
Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been...
3.
Lancaster T, Creese B, Escott-Price V, Driver I, Menzies G, Khan Z, et al.
Alzheimers Res Ther
. 2023 Dec;
15(1):213.
PMID: 38087383
Background: Genome-wide association studies demonstrate that Alzheimer's disease (AD) has a highly polygenic architecture, where thousands of independent genetic variants explain risk with high classification accuracy. This AD polygenic risk...
4.
Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease
McLauchlan D, Lancaster T, Craufurd D, Linden D, Rosser A
Brain Commun
. 2022 Nov;
4(6):fcac278.
PMID: 36440100
Depression is more common in neurodegenerative diseases such as Huntington's disease than the general population. Antidepressant efficacy is well-established for depression within the general population: a recent meta-analysis showed serotonin...
5.
Hulsebosch S, Pires J, Bannasch M, Lancaster T, Delpero A, Ragupathy R, et al.
J Vet Intern Med
. 2022 May;
36(4):1211-1219.
PMID: 35621084
Background: For the treatment of diabetes mellitus (DM) in dogs, novel insulins with decreased injection frequency while maintaining safety and efficacy are desirable. Insulin fused with immunoglobulin-fragment-crystallizable (Fc) has an...
6.
Comas-Forgas R, Lancaster T, Calvo-Sastre A, Sureda-Negre J
Heliyon
. 2021 Nov;
7(10):e08233.
PMID: 34722942
Academic institutions worldwide have had to adapt their methods of teaching and assessment due to COVID-19. In many Spanish universities exams moved online, affording students with opportunities to breach academic...
7.
Gilor C, Hulsebosch S, Pires J, Bannasch M, Lancaster T, Delpero A, et al.
J Vet Intern Med
. 2021 Jun;
35(5):2123-2130.
PMID: 34190365
Background: Treatment of diabetes mellitus (DM) in cats typically requires insulin injections q12h-q24h, posing a major compliance barrier for caregivers. Novel treatments enabling decreased injection frequency while maintaining safety are...
8.
McLauchlan D, Lancaster T, Craufurd D, Linden D, Rosser A
Mov Disord
. 2019 Jul;
34(9):1381-1391.
PMID: 31361357
Background: Apathy is a deficit in goal-directed behavior that significantly affects quality of life and function. It is common in Huntington's disease and other disorders affecting corticostriatal pathways. Deficits in...
9.
El Ters N, Claassen C, Lancaster T, Barnette A, Eldridge W, Yazigi F, et al.
Am J Perinatol
. 2018 Dec;
36(11):1198-1204.
PMID: 30566998
Objectives: Conventional neonatology practice is to place umbilical venous catheters (UVCs) in central position and to limit the use of low-lying catheters. Our objectives were to describe the practices and...
10.
Schump E, Lancaster T, Sparks D, Weatherstone K, Holcomb R
Adv Neonatal Care
. 2016 Aug;
16(5):E3-E10.
PMID: 27533331
Background: Early initiation of therapeutic hypothermia (TH) for the treatment of hypoxic ischemic encephalopathy (HIE) has been shown to improve outcomes. Many of these patients require transport to treatment facilities....